M&A Continues - Eli Lilly Ponies Up $1.4B for Point Biopharma

Week Ending September 29th, 2023

• Biotech: 8 Transactions (4 Follow-Ons, 2 PIPEs, and 2 RDs) totaling just under $2 Billion

• Med Tech: No Current Week Transactions

2023 YTD

• 134 Biotech transactions totaling just under $20 Billion v. 2022: 113 Biotech transactions totaling just under $14 Billion

• 15 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million

Private Transactions:

• Biotech: 182 Transactions / 53 European Transactions

• Med Tech: 100 US Transactions / 33 European Transactions

October Major Transactions:

• AbbVie acquired Mitokinin - $110M

• Kyowa Kirin acquired Orchard Therapeutics - $387M; $16/Share

• Eli Lilly acquired Point Biopharma - $1.4B; $12.50/Share
  

September Major Transactions:

• Alfasigma acquired Intercept Pharmaceuticals - $794M; $19/Share

August Major Transactions:

• Otsuka Pharmaceutical acquired Mindset Pharma - $59M; $0.75/Share

• Harmony Biosciences acquired Zynerba Pharmaceuticals - $60M; $1.11/Share

• Regeneron acquired Decibel Therapeutics - $107M; $4/Share